These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33551091)

  • 21. Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients.
    De Donatis D; Porcelli S; Zernig G; Mercolini L; Giupponi G; Serretti A; Conca A; Florio V
    World J Biol Psychiatry; 2022 Mar; 23(3):183-190. PubMed ID: 34096828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression.
    Hole K; Arnestad M; Molden E; Haslemo T
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):281-285. PubMed ID: 33905640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced clearance of venlafaxine in a combined treatment with quetiapine.
    Paulzen M; Schoretsanitis G; Hiemke C; Gründer G; Haen E; Augustin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():116-121. PubMed ID: 29702137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
    Berm EJ; Brummel-Mulder E; Paardekooper J; Hak E; Wilffert B; Maring JG
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2349-53. PubMed ID: 24493333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients.
    Haslemo T; Eliasson E; Jukić MM; Ingelman-Sundberg M; Molden E
    Br J Clin Pharmacol; 2019 Jan; 85(1):194-201. PubMed ID: 30312494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.
    Shams ME; Arneth B; Hiemke C; Dragicevic A; Müller MJ; Kaiser R; Lackner K; Härtter S
    J Clin Pharm Ther; 2006 Oct; 31(5):493-502. PubMed ID: 16958828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
    Castanares-Zapatero D; Gillard N; Capron A; Haufroid V; Hantson P
    Forensic Sci Int; 2016 Sep; 266():e48-e51. PubMed ID: 27328779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.
    Kuzin M; Schoretsanitis G; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Clin Pharmacokinet; 2018 Jun; 57(6):729-737. PubMed ID: 28866861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A poor metabolizer of both CYP2C19 and CYP2D6 identified by mechanistic pharmacokinetic simulation in a fatal drug poisoning case involving venlafaxine.
    Jornil J; Nielsen TS; Rosendal I; Ahlner J; Zackrisson AL; Boel LW; Brock B
    Forensic Sci Int; 2013 Mar; 226(1-3):e26-31. PubMed ID: 23332809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.
    Whyte EM; Romkes M; Mulsant BH; Kirshne MA; Begley AE; Reynolds CF; Pollock BG
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):542-9. PubMed ID: 16642541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
    Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P
    Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
    Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI
    J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.
    Mulder H; Herder A; Wilmink FW; Tamminga WJ; Belitser SV; Egberts AC
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):107-14. PubMed ID: 16294366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.
    Fukuda T; Yamamoto I; Nishida Y; Zhou Q; Ohno M; Takada K; Azuma J
    Br J Clin Pharmacol; 1999 Apr; 47(4):450-3. PubMed ID: 10233212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of Hepatic CYP3A4 and 2D6 Activity Using Radioiodine-Labeled
    Mizutani A; Kobayashi M; Aibe R; Muranaka Y; Nishi K; Kitamura M; Suzuki C; Nishii R; Shikano N; Magata Y; Ishida Y; Kunishima M; Kawai K
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes.
    Paulzen M; Schoretsanitis G; Gründer G; Franz C; Stingl JC; Augustin M
    J Affect Disord; 2020 Apr; 266():578-584. PubMed ID: 32056930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
    Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
    Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.
    Jessel CD; Mostafa S; Potiriadis M; Everall IP; Gunn JM; Bousman CA
    Pharmacogenet Genomics; 2020 Sep; 30(7):145-152. PubMed ID: 32433340
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.